English | Español
Robert Hadley | Apr 16, 2017

XGEVA pending approval for myeloma patients
Robert Hadley | Apr 15, 2017

Toujeo maker touts drug’s ability to lower blood sugar
Cheyenne Dickerson | Apr 15, 2017

Sinema named BIO Legislator of the Year

Ruth de Jauregui | Apr 14, 2017

FDA panel reviews license application for potential hemophilia B treatment
Robert Hadley | Apr 14, 2017

Campaign hopes to spur CPR training among minorities
Ruth de Jauregui | Apr 14, 2017

Research casts new light on gene mutations and ALS
Erianne Leatherman | Apr 14, 2017

CMS releases final updates for Medicare Advantage, drug plans
Erianne Leatherman | Apr 14, 2017

BioCryst reports encouraging results in Phase 2 APeX-1 trial of hereditary angioedema treatment

Trending
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’